Cargando…
CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
INTRODUCTION: Gallbladder cancer (GBC) is a highly malignant biliary tumor with a poor prognosis. As existing therapies for advanced metastatic GBC are rarely effective, there is an urgent need to identify more effective targets for treatment. METHODS: Hub genes of GBC were identified by bioinformat...
Autores principales: | Huang, Maotuan, Zhong, Fuxiu, Chen, Mingyuan, Hong, Lingju, Chen, Weihong, Abudukeremu, Xiahenazi, She, Feifei, Chen, Yanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232967/ https://www.ncbi.nlm.nih.gov/pubmed/37274251 http://dx.doi.org/10.3389/fonc.2023.1156177 |
Ejemplares similares
-
cIAP1 promotes proliferation and migration and prevents apoptosis in gallbladder cancer in vitro
por: Su, Wei, et al.
Publicado: (2019) -
CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
por: Li, Guo-Sheng, et al.
Publicado: (2023) -
Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer
por: Lin, Kang, et al.
Publicado: (2020) -
CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification
por: Wang, Gang, et al.
Publicado: (2023) -
CEP Biomarkers as Potential Tools for Monitoring Therapeutics
por: Renganathan, Kutralanathan, et al.
Publicado: (2013)